OOIR: Observatory of International Research

Papers

(The TQCC of Clinical & Translational Immunology is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)

Article	Citations
	107
	90
SARS‐CoV‐2‐associated T‐cell infiltration in the central nervous system	51
The spectrum of B cells in the pathogenesis, diagnosis and therapeutic applications of immunoglobulin G4‐related disease	40
Circulating cytokine and chemokine patterns associated with cytomegalovirus reactivation after stem cell transplantation	38
Characteristics of PD‐1⁺CD4⁺ T cells in peripheral blood and synovium of rheumatoid arthritis patients	37
Biomarkers to predict and diagnose pulmonary complications in children post haematopoietic stem cell transplant	34
Impact of adaptive natural killer cells, KLRC2 genotype and cytomegalovirus reactivation on late mortality in patients with severe COVID‐19 lung disease	31
	27
	26
Heterologous booster vaccination with CoronaVac following prime vaccination with mRNA vaccine	25
Effects of extremely preterm birth on cytokine and chemokine responses induced by T‐cell activation during infancy	24
Mass cytometry analysis reveals altered immune profiles in patients with coronary artery disease	24
	24
Retrospective analysis of the efficacy of adjuvant cytokine‐induced killer cell immunotherapy combined with chemotherapy in colorectal cancer patients after surgery	23
The contribution of the alternative pathway in complement activation on cell surfaces depends on the strength of classical pathway initiation	23
	22
Targeting BMI‐1 to deplete antibody‐secreting cells in autoimmunity	22
Endogenous bystander killing mechanisms enhance the activity of novel FAP‐specific CAR‐T cells against glioblastoma	21
Adeno‐associated viral vectors encoding anti‐P2X7 nanobodies reduce graft‐versus‐host disease in a humanised mouse model	21
Validation and performance of a multiplex serology assay to quantify antibody responses following SARS‐CoV‐2 infection or vaccination	21
Inhibitory effect of hydroxychloroquine on glucocorticoid‐induced osteoporosis in lupus therapy	20
Increased mast cell activation in eosinophilic chronic obstructive pulmonary disease	19
Naturally acquired adaptive immunity to Streptococcus pneumoniae is impaired in rheumatoid arthritis patients	19
Optimised modular anti‐FLAG CAR T cells for solid tumor therapy	19

	19
Siglec‐1, an easy and contributory inflammation marker in rheumatology	18
	17
Robust immunity to influenza vaccination in haematopoietic stem cell transplant recipients following reconstitution of humoral and adaptive immunity	17
Genome‐wide association study and polygenic risk scores of eosinophilia in Taiwan	17
	17
	16
Identification of distinct immune signatures in inclusion body myositis by peripheral blood immunophenotyping using machine learning models	16
Identification of polo‐like kinase 1 as a therapeutic target in murine lupus	16
Increased amphiregulin expression by CD4⁺ T cells from individuals with asymptomatic Leishmania donovani infection	15
High KRT17 expression in tumour budding indicates immunologically ‘hot’ tumour budding and predicts good survival in patients with colorectal cancer	15
	14
Exploring NK cell receptor dynamics in paediatric leukaemias: implications for immunotherapy and prognosis	14
Skin immunity and inflammation: cellular interactions and communication	14
Prediction of intravenous immunoglobulin retreatment in children with Kawasaki disease using models combining lymphocyte subset and cytokine profile in an East Asian cohort	14
Immunoregulatory effects of testosterone supplementation combined with exercise training in men with Inclusion Body Myositis: a double‐blind, placebo‐controlled, cross‐over trial	13
Human axillary lymph node T follicular helper (Tfh) and Precursor‐Tfh cells exhibit functional flexibility following seasonal influenza vaccination	13
CD39 expression defines exhausted CD4⁺ T cells associated with poor survival and immune evasion in human gastric cancer	13
Genome‐wide off‐target analyses of CRISPR/Cas9‐mediated T‐cell receptor engineering in primary human T cells	13
A preclinical study of allogeneic CD19 chimeric antigen receptor double‐negative T cells as an off‐the‐shelf immunotherapy drug against B‐cell malignancies	13
Data standards for single‐cell RNA‐sequencing of paediatric cancer	13
A unique cytotoxic CD4 ⁺ T cell‐signature defines critical COVID‐19	12
	12
Epstein–Barr virus infection, B‐cell dysfunction and other risk factors converge in gut‐associated lymphoid tissue to drive the immunopathogenesis of multiple sclerosis: a hypothesis	12
Hypoxia‐inducible factor‐1α regulates the interleukin‐6 production by B cells in rheumatoid arthritis	12
Effect of washed versus unwashed red blood cells on transfusion‐related immune responses in preterm newborns	11
Importance of crosstalk between the microbiota and the neuroimmune system for tissue homeostasis	11
Targeting SARS‐CoV ‐2 infection through CAR‐T ‐like bispecific T cell engagers incorporating	11
Pulmonary complications post allogeneic haematopoietic stem cell transplant in children	11
Inflammasome activation: from molecular mechanisms to autoinflammation	11
	10
Infiltrating characteristics and prognostic value of tertiary lymphoid structures in resected gastric neuroendocrine neoplasm patients	10
Long‐term effects of influenza and Bacille Calmette–Guérin vaccination on systemic inflammation	10
	9
Adoptive T‐cell therapy targeting Epstein–Barr virus as a treatment for multiple sclerosis	9
Multi‐omics integration reveals a nonlinear signature that precedes progression of lung fibrosis	9
Administration of an LXR agonist promotes atherosclerotic lesion remodelling in murine inflammatory arthritis	9
Serological responses and clinical outcomes following a three‐dose primary COVID‐19 vaccine schedule in kidney transplant recipients and people on dialysis	9
Elucidating novel immune profiles for predicting infection in high‐risk cohorts: a pilot study in patients with relapsed and refractory chronic lymphocytic leukaemia	9
Spatial proteomic profiling of tumor and stromal compartments in non‐small‐cell lung cancer identifies signatures associated with overall survival	9
Effect of Bacille Calmette–Guérin vaccination on immune responses to SARS‐CoV‐2 and COVID‐19 vaccination	8
Genetic differences in the HLA region contribute to the variability in SARS‐CoV‐2 vaccine responsiveness of older persons: the Doetinchem Cohort Study	8
Sex‐bias in CD8⁺ T‐cell stemness and exhaustion in cancer	8
Graft CD8 T‐cell‐based risk system predicts survival in antithymocyte globulin‐based myeloablative haploidentical peripheral blood stem cell transplantation	8
Antigen‐specific polyfunctional cytotoxic T cells differentiate intraocular from peripheral blood immune responses in posterior uveitis	8
Homologous peptides derived from influenza A, B and C viruses induce variable CD8⁺ T cell responses with cross‐reactive potential	8
Blood transcriptomics identifies immune signatures indicative of infectious complications in childhood cancer patients with febrile neutropenia	8
Memory stem T cells modified with a redesigned CD30‐chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma	8
Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients	8
Understanding the tumor microenvironment in head and neck squamous cell carcinoma	8